Aytu BioPharma Inc. (AYTU)
NASDAQ: AYTU
· Real-Time Price · USD
1.27
0.06 (4.70%)
At close: May 09, 2025, 12:30 PM
4.70% (1D)
Bid | 1.24 |
Market Cap | 7.87M |
Revenue (ttm) | 68.76M |
Net Income (ttm) | -5.25M |
EPS (ttm) | -2.08 |
PE Ratio (ttm) | -0.61 |
Forward PE | 0.89 |
Analyst | n/a |
Ask | 1.29 |
Volume | 3,559 |
Avg. Volume (20D) | 37,081 |
Open | 1.27 |
Previous Close | 1.21 |
Day's Range | 1.22 - 1.29 |
52-Week Range | 0.95 - 3.45 |
Beta | -0.10 |
About AYTU
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AYTU
Website n/a
2 months ago
-0.72%
Aytu BioPharma shares are trading higher after the...
Unlock content with
Pro Subscription
5 months ago
-11.43%
Aytu BioPharma shares are trading lower. The company reported Q1 financial results.

2 weeks ago · accessnewswire.com
Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025Company to conduct 1x1 meetings on April 24, 2025 DENVER, CO / ACCESS Newswire / April 21, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on comm...

2 months ago · accessnewswire.com
Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial ResultsNet income of $0.8 million Adjusted EBITDA1 of $1.3 million Pediatric Portfolio net revenue up 86% sequentially First quarterly sequential prescription increase for both ADHD and Pediatric portfolios ...